Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

43.42
Delayed Data
As of Sep 23
 -0.16 / -0.37%
Today’s Change
36.71
Today|||52-Week Range
45.58
+9.15%
Year-to-Date

Stock Price Forecast

The 24 analysts offering 12-month price forecasts for GlaxoSmithKline have a median target of 47.69, with a high estimate of 53.61 and a low estimate of 35.10. The median estimate represents a +9.83% increase from the last price of 43.42.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Hold stock in GlaxoSmithKline. This rating has held steady since September, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.77
Sales
$9.6B
Reporting Date
Oct 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 20.45%
 
 
 
 
 
 
Growthannually 13.78%
 
 
 
 
 
 

Sales

Growthquarterly 12.26%
 
 
 
 
 
 
Growthannually 0.61%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.